Objective:

To report the retraction of a study on lycorine's role in angiogenesis inhibition.

Key Findings:

• The article was retracted due to concerns about data integrity.
• Overlap in data presentation was noted in Figure 2b, involving four conditions.
• The authors did not address the concerns raised by the editors.

Interpretation:

The editors no longer have confidence in the article's data and conclusions.

Limitations:

• No response was received from the authors regarding the concerns raised in the retraction.

Conclusion:

The study has been retracted due to unresolved data integrity issues.

Sources:

• BMC Cancer